2014
DOI: 10.3310/hta18500
|View full text |Cite
|
Sign up to set email alerts
|

Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review

Abstract: The National Institute for Health Research Health Technology Assessment programme.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
25
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 25 publications
(27 citation statements)
references
References 159 publications
0
25
0
2
Order By: Relevance
“…First, as mentioned above, most of the PIP prescription (69.9 %) was anxiolytics and hypnotics. To date, no intervention for treatment-resistant anxiety in the elderly inpatients has proven its efficacy (Barton et al 2014). Most of the patients may therefore be administered long-term anxiolytic medications due to the lack of effective alternative interventions.…”
Section: Discussionmentioning
confidence: 99%
“…First, as mentioned above, most of the PIP prescription (69.9 %) was anxiolytics and hypnotics. To date, no intervention for treatment-resistant anxiety in the elderly inpatients has proven its efficacy (Barton et al 2014). Most of the patients may therefore be administered long-term anxiolytic medications due to the lack of effective alternative interventions.…”
Section: Discussionmentioning
confidence: 99%
“…Included studies were published between 1986 and 2018. They consisted of eight narrative reviews (Bakker, Van Balkom, & Stein, ; Bandelow et al, ; Bystritsky, ; Chen & Tsai, ; Holt & Lydiard, ; Lorenz, Jackson, & Saitz, ; Pollack, ; Starcevic, ), five systematic reviews (Barton et al, ; Cosci & Fava, ; Ipser et al, ; Patterson & Van Ameringen, ; Samuel, Zimovetz, Gabriel, & Beard, ), of which three also performed meta‐analyses (Barton et al, ; Ipser et al, ; Patterson & Van Ameringen, ), seven treatment guidelines/algorithms (Bandelow, ; Bandelow, Zohar, Hollander, Kasper, & Moller, ; National Institute for Health & Clinical Excellence, ; Stein et al, ; Stein et al, ; Stein, ; Stein, ), three book chapters (Baldwin, Polkinghorn, Lerer, & Stahl, ; Deligiannidis & Rothschild, ; Van Ameringen, Mancini, Patterson, & Stein, ), 21 open‐label trials (Gabriel & Violato, ; Gabriel, ; George et al, ; Glue et al, , ; Heldt et al, ; Heldt et al, ; Hoge et al, ; Hollifield, Thompson, Ruiz, & Uhlenhuth, ; Katzman et al, ; Kinrys, Vasconcelos E Sa, & Nery, ; Menza, Dobkin, & Marin, ; Ociskova, Prasko, Latalova, Kamaradova, & Grambal, ; Pallanti & Quercioli, ; Pollack, Otto, Kaspi, Hammerness, & Rosenbaum, ; Simon et al, ; Snyderman et al, ; Solbakken & Abbass, , ; Worthington III, Kinrys, Wygant, & Pollack, ; Yoshinaga et al, ), eight RCTs (Brawman‐Mintzer, Knapp, & Nietert, ; Castle, Gray, Neehoff, & Glue, ; Gloster et al, ; Hirschmann et al, ; Lohoff et al, ; Pollack et al, ; Rickels et al, ; Simon et al, ), ...…”
Section: Resultsmentioning
confidence: 99%
“…Up till now, a widely used definition for treatment resistance in anxiety disorders does not exist (Barton, Karner, Salih, Baldwin, & Edwards, ; Chen & Tsai, ; Roy‐Byrne, ; Starcevic, ; Stein, ). This is surprising because it is well known that a substantial proportion of adults with Anxiety Disorders experience suboptimal treatment results after evidence‐based treatments (Bruce et al, ; Huh, Goebert, Takeshita, Lu, & Kang, ; Ramsawh, Raffa, Edelen, Rende, & Keller, ).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations